Improving The FDA’s Regulatory Process Can Enhance Treatment Option

Improving The FDA’s Regulatory Process Can Enhance Treatment Option

Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine?

Read the full article at Forbes.com